3 results
Approved WMORecruiting
Primary ObjectiveTo demonstrate that avelumab in combination with axitinib is superior to sunitinib monotherapy in prolonging PFS or OS in the first-line treatment of PD-L1 positive patients with aRCC.Secondary Objectives* To demonstrate that…
Approved WMOCompleted
In this study we want to determine the erlotinib concentrations in blood after administration of erlotinib with water or whole milk with and without an antacid .
Approved WMORecruiting
To determine the influence of esomeprazole on the AUC of regorafenib in patients with mCRC or GIST.